Company intelligence / Profile preview

IDRS Labs

Bangalore, Karnataka, Indiaidrslabs.com ↗

Ownership: Private
Development stage: Commercial

Overview

IDRS Labs is an ISO 9001:2015 certified specialty pharmaceutical CRO based in Bangalore, India. It partners with global pharma companies to develop complex products—ranging from injectables to oral formulations—supporting all phases of product development including formulation, analytical method validation, technology transfer, scale-up, manufacturing registration batches, and regulatory submissions. Many products developed by IDRS are now commercialized globally.

Modalities: Small moleculeBiologic
Industry: Contract Research Organization

Drug pipeline

2 assets

6-mercaptopurine

Commercial

Indications: Acute Lymphoblastic Leukemia

1 more asset in the full pipeline.

Request access →

Partnerships

Not specifically named; described as having strategic long-term partnerships with global pharmaceutical leaders.

Beyond the preview

Go deeper on IDRS Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IDRS Labs.

Explore the full profile